Cargando…

Inotropic effects of a single intravenous recommended dose of pimobendan in healthy dogs

We investigated the effects of an injectable pimobendan solution (0.15 mg/kg) on cardiac function in healthy dogs. Fifteen dogs were divided into placebo, intravenous pimobendan injection, and subcutaneous pimobendan injection groups. In the placebo, the heart rate, systolic and end-diastolic left v...

Descripción completa

Detalles Bibliográficos
Autores principales:	HORI, Yasutomo, TAIRA, Hiroto, NAKAJIMA, Yuji, ISHIKAWA, Yusyun, YUMOTO, Yuki, MAEKAWA, Yuya, OSHIRO, Akiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Veterinary Science 2018
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361644/ https://www.ncbi.nlm.nih.gov/pubmed/30404952 http://dx.doi.org/10.1292/jvms.18-0185

Ejemplares similares

Pharmacodynamics and Pharmacokinetics of Injectable Pimobendan and Its Metabolite, O-Desmethyl-Pimobendan, in Healthy Dogs
por: Pichayapaiboon, Poonavit, et al.
Publicado: (2021)

Pharmacokinetics of Pimobendan and Its Metabolite O-Desmethyl-Pimobendan Following Rectal Administration to Healthy Dogs
por: Her, Jiwoong, et al.
Publicado: (2020)

Comparison of the effects of long-term pimobendan and benazepril administration in normal cats
por: MIYAGAWA, Yuichi, et al.
Publicado: (2016)

Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure
por: MIZUNO, Masashi, et al.
Publicado: (2016)

Hemodynamic effect of pimobendan following intramuscular and intravenous administration in healthy dogs: A pilot study
por: Enokizono, Masayuki, et al.
Publicado: (2022)

Hyperferritinemia in Dogs with Splenic Hemangiosarcoma
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013)

Plasma N-Terminal Pro B-Type Natriuretic Peptide Concentrations in Dogs with Pulmonic Stenosis
por: KOBAYASHI, Keiya, et al.
Publicado: (2014)

Hyperferritinemia is associated with short survival time in dogs with multicentric lymphoma
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2015)

Large granular lymphocyte lymphoma in the skin and urinary bladder of a dog
por: ADACHI, Mami, et al.
Publicado: (2022)

Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease
por: McManamey, Anna K., et al.
Publicado: (2023)

Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease
por: HORI, Yasutomo, et al.
Publicado: (2018)

Change in Serum Ferritin Concentration in Experimentally Induced Anemia of Chronic Inflammation in Dogs
por: CHIKAZAWA, Seishiro, et al.
Publicado: (2013)

Plasma atrial natriuretic peptide and N-terminal pro B-type natriuretic peptide concentrations in dogs with right-sided congestive heart failure
por: KANNO, Nobuyuki, et al.
Publicado: (2015)

Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease
por: Sarcinella, Fabio, et al.
Publicado: (2019)

Preliminary Bioequivalence of an Oral Pimobendan Solution Formulation with Reference Solution Formulation in Beagle Dogs
por: Saengklub, Nakkawee, et al.
Publicado: (2022)

Pimobendan B from powder diffraction data
por: Zvirgzdins, Alvis, et al.
Publicado: (2013)

Repeated-Dose Pharmacodynamics of Pimobendan in Healthy Cats
por: Sugimoto, Keisuke, et al.
Publicado: (2022)

Long‐term administration of intravenous inotropes in advanced heart failure
por: Gentile, Piero, et al.
Publicado: (2021)

Vasopressor stays vasopressor and inotrope stays inotrope!
por: Luckner, Günter, et al.
Publicado: (2008)

Effects of pimobendan on left atrial transport function in cats
por: Kochie, Samantha L., et al.
Publicado: (2020)

Serum concentration and safety of intravenous drip versus subcutaneous administration of carboplatin in dogs
por: IWANO, Masataka, et al.
Publicado: (2021)

Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly
por: Iwanuk, Nayeli, et al.
Publicado: (2019)

Comparison of N-terminal pro-atrial natriuretic peptide and three cardiac biomarkers for discriminatory ability of clinical stage in dogs with myxomatous mitral valve disease
por: OGAWA, Mizuki, et al.
Publicado: (2021)

Trismus due to myotonia associated with hyperadrenocorticism in a dog
por: YOKOTA, Shunya, et al.
Publicado: (2023)

Vasopressin Is No Inotrope
por: Roeleveld, Peter Paul
Publicado: (2018)

Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study—A Randomized Clinical Trial
por: Boswood, A., et al.
Publicado: (2016)

Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial
por: Wess, Gerhard, et al.
Publicado: (2020)

The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study
por: Klein, Stephanie, et al.
Publicado: (2021)

Total inotrope exposure score: an extension of the vasoactive inotrope score
por: Bangalore, H, et al.
Publicado: (2015)

Safety and efficacy of intravenous administration for tranexamic acid-induced emesis in dogs with accidental ingestion of foreign substances
por: ORITO, Kensuke, et al.
Publicado: (2017)

Indirect arterial blood pressure measurement in healthy anesthetized cats using a device that combines oscillometry with photoplethysmography
por: HEISHIMA, Yasuhiro, et al.
Publicado: (2016)

Retrospective evaluation of pimobendan and sildenafil therapy for severe pulmonary hypertension due to lung disease and hypoxia in 28 dogs (2007–2013)
por: Murphy, Lisa A., et al.
Publicado: (2017)

Acute Effects of Pimobendan on Cardiac Function in Dogs With Tachycardia Induced Dilated Cardiomyopathy: A Randomized, Placebo-Controlled, Crossover Study
por: Abbott-Johnson, Kaitlin, et al.
Publicado: (2021)

Hemodynamic effects of intravenous paracetamol in critically ill children with septic shock on inotropic support
por: Nahum, Elhanan, et al.
Publicado: (2020)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Evaluation of a fixed-dose combination of benazepril and pimobendan in dogs with congestive heart failure: a randomized non-inferiority clinical trial
por: King, Jonathan N., et al.
Publicado: (2018)

Long‐term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy
por: Vollmar, A.C., et al.
Publicado: (2016)

Letter regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”
por: Oyama, Mark A., et al.
Publicado: (2021)

Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs
por: Pirintr, Prapawadee, et al.
Publicado: (2023)

Hydrolyzed diets may stimulate food-reactive lymphocytes in dogs
por: MASUDA, Kenichi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h74ofs8f4taibcn3qlndd5i7lp